Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cathy Eng

Showing results (171-180 of 315) with videos related to

Pageof 32
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 22, 2010
Oxaliplatin-mediated increase in spleen size as a biomarker for the development of hepatic sinusoidal injuryMichael J Overman, Dipen M Maru, Chusilp Charnsangavej, et al.
Cancer|June 22, 2010
A phase 1 study of hepatic arterial infusion of oxaliplatin in combination with systemic 5-fluorouracil, leucovorin, and bevacizumab in patients with advanced solid tumors metastatic to the liverApostolia M Tsimberidou, Siqing Fu, Chaan Ng, et al.
Cancer|February 18, 2011
Number of lymph nodes examined and prognosis among pathologically lymph node-negative patients after preoperative chemoradiation therapy for rectal adenocarcinomaChiaojung Jillian Tsai, Christopher H Crane, John M Skibber, et al.
Cancer|March 28, 2007
Predictors of tumor response and downstaging in patients who receive preoperative chemoradiation for rectal cancerPrajnan Das, John M Skibber, Miguel A Rodriguez-Bigas, et al.
Clinical Colorectal Cancer|January 28, 2012
Survival benefit associated with surgical oophorectomy in patients with colorectal cancer metastatic to the ovaryChristopher R Garrett, Ben George, Chitra Viswanathan, et al.
American Journal of Clinical Oncology|September 16, 2014
Definitive Chemoradiation for Squamous Cell Carcinoma of the RectumJared D Sturgeon, Christopher H Crane, Sunil Krishnan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 5, 2012
Genetic polymorphisms in MicroRNA-related genes as predictors of clinical outcomes in colorectal adenocarcinoma patientsMoubin Lin, Jian Gu, Cathy Eng, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 26, 2011
High survival rate after two-stage resection of advanced colorectal liver metastases: response-based selection and complete resection define outcomeAntoine Brouquet, Eddie K Abdalla, Scott Kopetz, et al.
Cancer|February 19, 2010
Validation and application of a module of the M. D. Anderson Symptom Inventory for measuring multiple symptoms in patients with gastrointestinal cancer (the MDASI-GI)Xin Shelley Wang, Loretta A Williams, Cathy Eng, et al.
Gut|November 1, 2017
Comparison of early radiological predictors of outcome in patients with colorectal cancer with unresectable hepatic metastases treated with bevacizumabThibault Mazard, Piyaporn Boonsirikamchai, Michael J Overman, et al.
Pageof 32

Showing results (171-180 of 315) with videos related to

Sort By:
Pageof 32
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 22, 2010
Oxaliplatin-mediated increase in spleen size as a biomarker for the development of hepatic sinusoidal injuryMichael J Overman, Dipen M Maru, Chusilp Charnsangavej, et al.
Cancer|June 22, 2010
A phase 1 study of hepatic arterial infusion of oxaliplatin in combination with systemic 5-fluorouracil, leucovorin, and bevacizumab in patients with advanced solid tumors metastatic to the liverApostolia M Tsimberidou, Siqing Fu, Chaan Ng, et al.
Cancer|February 18, 2011
Number of lymph nodes examined and prognosis among pathologically lymph node-negative patients after preoperative chemoradiation therapy for rectal adenocarcinomaChiaojung Jillian Tsai, Christopher H Crane, John M Skibber, et al.
Cancer|March 28, 2007
Predictors of tumor response and downstaging in patients who receive preoperative chemoradiation for rectal cancerPrajnan Das, John M Skibber, Miguel A Rodriguez-Bigas, et al.
Clinical Colorectal Cancer|January 28, 2012
Survival benefit associated with surgical oophorectomy in patients with colorectal cancer metastatic to the ovaryChristopher R Garrett, Ben George, Chitra Viswanathan, et al.
American Journal of Clinical Oncology|September 16, 2014
Definitive Chemoradiation for Squamous Cell Carcinoma of the RectumJared D Sturgeon, Christopher H Crane, Sunil Krishnan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 5, 2012
Genetic polymorphisms in MicroRNA-related genes as predictors of clinical outcomes in colorectal adenocarcinoma patientsMoubin Lin, Jian Gu, Cathy Eng, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 26, 2011
High survival rate after two-stage resection of advanced colorectal liver metastases: response-based selection and complete resection define outcomeAntoine Brouquet, Eddie K Abdalla, Scott Kopetz, et al.
Cancer|February 19, 2010
Validation and application of a module of the M. D. Anderson Symptom Inventory for measuring multiple symptoms in patients with gastrointestinal cancer (the MDASI-GI)Xin Shelley Wang, Loretta A Williams, Cathy Eng, et al.
Gut|November 1, 2017
Comparison of early radiological predictors of outcome in patients with colorectal cancer with unresectable hepatic metastases treated with bevacizumabThibault Mazard, Piyaporn Boonsirikamchai, Michael J Overman, et al.
Pageof 32